Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes (original) (raw)

• Nolan, C.J., Damm, P. & Prentki, M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378, 169–181 (2011).
  Article Google Scholar
• Chen, L., Magliano, D.J. & Zimmet, P.Z. The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat. Rev. Endocrinol. 8, 228–236 (2012).
  Article CAS Google Scholar
• Tahrani, A.A., Bailey, C.J., Del Prato, S. & Barnett, A.H. Management of type 2 diabetes: new and future developments in treatment. Lancet 378, 182–197 (2011).
  Article CAS Google Scholar
• Vetere, A., Choudhary, A., Burns, S.M. & Wagner, B.K. Targeting the pancreatic β-cell to treat diabetes. Nat. Rev. Drug Discov. 13, 278–289 (2014).
  Article CAS Google Scholar
• Ashcroft, F.M. & Rorsman, P. Diabetes mellitus and the β cell: the last ten years. Cell 148, 1160–1171 (2012).
  Article CAS Google Scholar
• Rorsman, P. & Braun, M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 75, 155–179 (2013).
  Article CAS Google Scholar
• Ahrén, B. Islet G protein–coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 8, 369–385 (2009).
  Article Google Scholar
• Sassmann, A. et al. The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. J. Clin. Invest. 120, 2184–2193 (2010).
  Article CAS Google Scholar
• Ruiz de Azua, I., Gautam, D., Guettier, J.M. & Wess, J. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications. Trends Endocrinol. Metab. 22, 74–80 (2011).
  Article CAS Google Scholar
• Mancini, A.D. & Poitout, V. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Trends Endocrinol. Metab. 24, 398–407 (2013).
  Article CAS Google Scholar
• Campbell, J.E. & Drucker, D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 17, 819–837 (2013).
  Article CAS Google Scholar
• Rosengren, A.H. et al. Overexpression of α2A-adrenergic receptors contributes to type 2 diabetes. Science 327, 217–220 (2010).
  Article CAS Google Scholar
• Regard, J.B. et al. Probing cell type–specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J. Clin. Invest. 117, 4034–4043 (2007).
  CAS Google Scholar
• Stoddart, L.A., Smith, N.J. & Milligan, G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 60, 405–417 (2008).
  Article CAS Google Scholar
• Ulven, T. Short-chain free fatty acid receptors FFAR2/GPR43 and FFAR3/GPR41 as new potential therapeutic targets. Front. Endocrinol. (Lausanne) 3, 111 (2012).
  Article Google Scholar
• Kebede, M.A., Alquier, T., Latour, M.G. & Poitout, V. Lipid receptors and islet function: therapeutic implications? Diabetes Obes. Metab. 11 (suppl. 4), 10–20 (2009).
  Article CAS Google Scholar
• Bjursell, M. et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 300, E211–E220 (2011).
  Article CAS Google Scholar
• Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein–coupled receptor FFAR2. Diabetes 61, 364–371 (2012).
  Article CAS Google Scholar
• Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
  Article Google Scholar
• Samuel, B.S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein–coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 105, 16767–16772 (2008).
  Article CAS Google Scholar
• Bellahcene, M. et al. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br. J. Nutr. 109, 1755–1764 (2013).
  Article CAS Google Scholar
• Lin, H.V. et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7, e35240 (2012).
  Article CAS Google Scholar
• Zaibi, M.S. et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 584, 2381–2386 (2010).
  Article CAS Google Scholar
• Ravassard, P. et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 121, 3589–3597 (2011).
  Article CAS Google Scholar
• Brown, A.J. et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319 (2003).
  Article CAS Google Scholar
• Le Poul, E. et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481–25489 (2003).
  Article CAS Google Scholar
• Buckley, B.M. & Williamson, D.H. Origins of blood acetate in the rat. Biochem. J. 166, 539–545 (1977).
  Article CAS Google Scholar
• Smith, R.F., Humphreys, S. & Hockaday, T.D. The measurement of plasma acetate by a manual or automated technique in diabetic and non-diabetic subjects. Ann. Clin. Biochem. 23, 285–291 (1986).
  Article CAS Google Scholar
• Todesco, T. et al. Plasma acetate levels in a group of obese diabetic, obese normoglycemic, and control subjects and their relationships with other blood parameters. Am. J. Gastroenterol. 88, 751–755 (1993).
  CAS Google Scholar
• Nøhr, M.K. et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154, 3552–3564 (2013).
  Article Google Scholar
• Tazoe, H. et al. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 59 (suppl. 2), 251–262 (2008).
  Google Scholar
• Madison, B.B. et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277, 33275–33283 (2002).
  Article CAS Google Scholar
• Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305–315 (1999).
  Article CAS Google Scholar
• Wolever, T.M., Josse, R.G., Leiter, L.A. & Chiasson, J.L. Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805–811 (1997).
  Article CAS Google Scholar
• Skutches, C.L., Holroyde, C.P., Myers, R.N., Paul, P. & Reichard, G.A. Plasma acetate turnover and oxidation. J. Clin. Invest. 64, 708–713 (1979).
  Article CAS Google Scholar
• Yamashita, H., Kaneyuki, T. & Tagawa, K. Production of acetate in the liver and its utilization in peripheral tissues. Biochim. Biophys. Acta 1532, 79–87 (2001).
  Article CAS Google Scholar
• Pouteau, E., Nguyen, P., Ballevre, O. & Krempf, M. Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes. Proc. Nutr. Soc. 62, 87–93 (2003).
  Article CAS Google Scholar
• Layden, B.T., Yalamanchi, S.K., Wolever, T.M., Dunaif, A. & Lowe, W.L. Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab. Syndr. Obes. 5, 49–55 (2012).
  Article CAS Google Scholar
• Sakakibara, I. et al. Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2. Cell Metab. 9, 191–202 (2009).
  Article CAS Google Scholar
• Tiengo, A., Valerio, A., Molinari, M., Meneghel, A. & Lapolla, A. Effect of ethanol, acetaldehyde, and acetate on insulin and glucagon secretion in the perfused rat pancreas. Diabetes 30, 705–709 (1981).
  Article CAS Google Scholar
• Miyazaki, J. et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126–132 (1990).
  Article CAS Google Scholar
• Muyrers, J.P., Zhang, Y., Testa, G. & Stewart, A.F. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 27, 1555–1557 (1999).
  Article CAS Google Scholar
• Ahmed, K. et al. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab. 11, 311–319 (2010).
  Article CAS Google Scholar
• van den Hoek, A.M. et al. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am. J. Physiol. Endocrinol. Metab. 292, E238–E245 (2007).
  Article CAS Google Scholar
• Li, D.S., Yuan, Y.H., Tu, H.J., Liang, Q.L. & Dai, L.J. A protocol for islet isolation from mouse pancreas. Nat. Protoc. 4, 1649–1652 (2009).
  Article CAS Google Scholar
• Campbell, C.F. in Mouse Cell Culture: Methods and Protocols Vol. 633 (eds. Ward, A. & Tosh, D.) Ch. 14, 197–206 (Springer Science and Business Media, 2010).